Institutional investors purchased a net $12.8 million shares of TXMD during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 69.65% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Generic industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EAM INVESTORS LLC Bought 319.1 Thousand shares of TherapeuticsMD Inc
THE CALIFORNIA PUBLIC EMPLOYEES ... Bought 61.7 Thousand shares of TherapeuticsMD Inc
TD ASSET MANAGEMENT, INC. Bought 53.5 Thousand shares of TherapeuticsMD Inc